Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

Heading into today, shares of the HIV and hepatitis C drugmaker had lost 9.82% over the past month, outpacing the Medical sector's loss of 14.16% and the S&P 500's loss of 13.47% in that time. The ...

Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with ...

With that said, let's consider two top dividend stocks that should navigate the current storm relatively well and continue ...

Human immunodeficiency virus, if untreated, causes acquired immunodeficiency syndrome (AIDS), and death. HIV is almost entirely preventable by using condoms, or by taking PrEP drugs. PrEP drugs do not ...

While Gilead is eliminating 149 positions at its headquarters in Foster City, Roche is letting go of 108 workers at its ...

Georgia lawmakers are hoping to pass a bill before the legislative session ends Friday that would allow pharmacists to ...

South Florida, an area with the highest rate of HIV/AIDS in the country, is already starting to feel the effects of the Trump ...

Explore the top-performing Nasdaq 100 stocks this year as the index moves into a technical bear market this year.

Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...